Oxford Endovascular

Developer of treatment device for neurovascular disease

placeOxford, England, United Kingdom calendar_todayFounded 2015 groups7 employees language oxfordendovascular.com

Registered entities

Innovation

5 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 113 times.

YearFilings
20172
20182
20191
20204
20212
20223
20233
20242
20252

Investor mix

13 investors on record; lead investors include Vulpes Investment Management.

Investor typeCountShare
Venture capital323%
Private equity18%
Accelerator & incubator431%
Other / undisclosed538%
Coming soon